Informação sobre produto
- L-Aspartamide, N-[19-(9H-fluoren-9-yl)-1,17-dioxo-4,7,10,13,18-pentaoxa-16-azanonadec-1-yl]-L-alanyl-L-alanyl-N1-[4-(hydroxymethyl)phenyl]-
- N-[19-(9H-Fluoren-9-yl)-1,17-dioxo-4,7,10,13,18-pentaoxa-16-azanonadec-1-yl]-L-alanyl-L-alanyl-N1-[4-(hydroxymethyl)phenyl]-L-aspartamide
Fmoc-PEG4-Ala-Ala-ASN-PAB is a PEG protected peptide that belongs to the family of PEG products. It is a pegylated peptide, meaning it has been modified with polyethylene glycol (PEG) to enhance its stability and prolong its half-life in the body. Fmoc-PEG4-Ala-Ala-ASN-PAB is commonly used in pharmaceutical research and drug development due to its improved pharmacokinetic properties. Its PEGylation allows for increased solubility, reduced immunogenicity, and enhanced bioavailability. This makes it an ideal choice for applications requiring prolonged release or targeted delivery of therapeutic agents.
Propriedades químicas
Consulta técnica sobre: 3D-FHD04857 Fmoc-PEG4-Ala-Ala-ASN-PAB
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
